(Q68249373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651610%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651610%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

21 October 2022

5

A. Z. Kapikian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651610

21 October 2022

author name string

T. Vesikari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651610

21 October 2022

T. Varis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651610

21 October 2022

K. Green

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651610

21 October 2022

J. Flores

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1651610

21 October 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651610%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:0264410X9190060J?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

https://api.elsevier.com/content/article/PII:0264410X9190060J?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

21 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651610%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651610%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651610%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

334-339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651610%20AND%20SRC:MED&resulttype=core&format=json

Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination

23 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants

21 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Field trial of rhesus rotavirus vaccine in infants

21 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Prolonged efficacy of rhesus rotavirus vaccine in Swedish children

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Perspective on the development and deployment of rotavirus vaccines.

21 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

21 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006.

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

21 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children.

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children

21 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development

21 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90060-J

21 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1651610%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference